Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Gene therapy for infectious diseases
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gene therapy for infectious diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Infectious Diseases
100%
Gene Therapy
100%
Nucleic Acids
25%
Lymphocytes
25%
Infectious Agents
25%
Multiple Stages
25%
Pathogen-specific
25%
Antisense RNA
25%
Clinical Management
25%
Immunotherapeutic Approaches
25%
RNA-RNA
25%
Single-chain Antibody
25%
Ribozyme
25%
Genetic Vaccine
25%
RNA Decoy
25%
Catalytic RNA
25%
Antisense DNA
25%
Life Cycle Stages
25%
Medicine and Dentistry
Infection
100%
Gene Therapy
100%
Ribozyme
50%
Pathogen
25%
Clinical Management
25%
Nucleic Acid
25%
Complementary DNA
25%
Life Cycle
25%
Complementary RNA
25%
Single Chain Fragment Variable Antibody
25%
Lymphocyte
25%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Infectious Agent
50%
RNA
50%
Ribozyme
50%
Antisense
25%
Genetics
25%
Nucleic Acid
25%
Life Cycle
25%
Single-Chain Variable Fragment
25%
Lymphocyte
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Infectious Agent
66%
Ribozyme
66%
Complementary DNA
33%
Nucleic Acid
33%
Complementary RNA
33%
Single Chain Fragment Variable Antibody
33%
Immunology and Microbiology
Infectious Disease
100%
Infectious Agent
66%
Antisense
33%
Life Cycle
33%
Single-Chain Variable Fragment
33%
Lymphocyte
33%
Veterinary Science and Veterinary Medicine
Lymphocyte
100%